A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.

This study is ongoing, but not recruiting participants.

Study NCT00394277 Information provided by Hoffmann-La Roche

First Received: October 30, 2006 Last Updated: September 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2009
Estimated Primary Completion Date:	No date given